In an article on "The Use of Human Anti-haemophilic Globulin (Fraction I-O) in Haemophilia A and in von Willebrand's Disease" published in Acta Haematologica, the development of antihaemophilic globulins (AHG) was reported which had treated 59 patients by 1959 in Sweden.